Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

C A Bellera, N Penel, M Ouali, S Bonvalot, PG Casali, OS Nielsen, M Delannes, S Litiere, F Bonnetain, T S Dabakuyo, R S Benjamin, JY Blay, BN Bui, F Collin, T F Delaney, F Duffaud, T Filleron, M Fiore, H Gelderblom, S (Shanti) GeorgeR Grimer, P Grosclaude, A Gronchi, R Haas, P Hohenberger, R Issels, A Italiano, V Jooste, A Krarup-Hansen, C Pechoux, C Mussi, O Oberlin, S Patel, S Piperno-Neumann, C Raut, I Ray-Coquard, P Rutkowski, S Schuetze, Stefan Sleijfer, E Stoeckle, M Glabbeke, P Woll, S Gourgou-Bourgade, S Mathoulin-Pelissier

Research output: Contribution to journalArticleAcademicpeer-review

42 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)865-872
Number of pages8
JournalAnnals of Oncology
Issue number5
Publication statusPublished - 2015

Research programs

  • EMC MM-03-86-01

Cite this